Johnson & Johnson Price to Sales Ratio 2006-2021 | JNJ

Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of September 17, 2021 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2021-09-17 164.75 4.93
2021-06-30 163.76 $33.39 4.90
2021-03-31 162.37 $31.54 5.15
2020-12-31 154.52 $30.94 4.99
2020-09-30 145.15 $30.25 4.80
2020-06-30 136.20 $30.12 4.52
2020-03-31 126.12 $30.88 4.08
2019-12-31 139.39 $30.55 4.56
2019-09-30 122.78 $30.30 4.05
2019-06-30 132.18 $29.99 4.41
2019-03-31 131.76 $30.01 4.39
2018-12-31 120.84 $29.91 4.04
2018-09-30 128.56 $29.79 4.31
2018-06-30 112.15 $29.51 3.80
2018-03-31 117.58 $28.73 4.09
2017-12-31 127.38 $27.86 4.57
2017-09-30 117.81 $26.99 4.36
2017-06-30 119.12 $26.21 4.54
2017-03-31 111.41 $25.95 4.29
2016-12-31 102.39 $25.74 3.98
2016-09-30 104.26 $25.58 4.08
2016-06-30 106.35 $25.27 4.21
2016-03-31 94.20 $24.98 3.77
2015-12-31 88.79 $24.90 3.57
2015-09-30 80.10 $24.94 3.21
2015-06-30 82.98 $25.29 3.28
2015-03-31 85.03 $25.75 3.30
2014-12-31 87.77 $25.91 3.39
2014-09-30 88.89 $25.91 3.43
2014-06-30 86.66 $25.56 3.39
2014-03-31 80.81 $24.96 3.24
2013-12-31 74.80 $24.78 3.02
2013-09-30 70.31 $24.65 2.85
2013-06-30 69.13 $24.60 2.81
2013-03-31 65.15 $24.30 2.68
2012-12-31 55.57 $24.00 2.32
2012-09-30 54.15 $23.61 2.29
2012-06-30 52.61 $23.32 2.26
2012-03-31 50.88 $23.40 2.17
2011-12-31 50.14 $23.42 2.14
2011-09-30 48.25 $23.17 2.08
2011-06-30 49.95 $22.79 2.19
2011-03-31 44.10 $22.30 1.98
2010-12-31 45.63 $22.06 2.07
2010-09-30 45.32 $22.38 2.02
2010-06-30 42.79 $22.40 1.91
2010-03-31 46.81 $22.40 2.09
2009-12-31 45.89 $22.20 2.07
2009-09-30 43.05 $21.62 1.99
2009-06-30 39.84 $21.84 1.82
2009-03-31 36.56 $22.15 1.65
2008-12-31 41.24 $22.41 1.84
2008-09-30 47.38 $22.54 2.10
2008-06-30 43.72 $22.05 1.98
2008-03-31 43.78 $21.45 2.04
2007-12-31 44.72 $20.94 2.14
2007-09-30 43.78 $20.08 2.18
2007-06-30 40.78 $19.45 2.10
2007-03-31 39.62 $18.76 2.11
2006-12-31 43.16 $17.96 2.40
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $434.939B $82.584B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $319.781B 0.00
Pfizer (PFE) United States $249.329B 14.16
Novo Nordisk (NVO) Denmark $241.084B 33.46
Eli Lilly (LLY) United States $221.573B 28.77
AbbVie (ABBV) United States $190.996B 9.15
Novartis AG (NVS) Switzerland $188.736B 14.02
Merck (MRK) United States $182.183B 12.47
AstraZeneca (AZN) United Kingdom $175.360B 24.93
Sanofi (SNY) $121.515B 13.39
GlaxoSmithKline (GSK) United Kingdom $105.307B 13.21
Bayer (BAYRY) Germany $52.972B 7.13
H Lundbeck (HLUYY) Denmark $5.383B 10.32
Innoviva (INVA) United States $1.059B 5.69